Lattice Biologics Ltd. LBLTF
OTC PK
| 06/30/2021 | 03/31/2021 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 155.45% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -- | -97.34% | |||
|
|
|||||
| Total Current Assets | -- | -97.34% | |||
| Net Property, Plant & Equipment | -- | -- | |||
| Long-term Investments | 0.00% | 0.00% | |||
| Goodwill | 0.00% | 0.00% | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | -75.54% | -72.93% | |||
|
|
|||||
| Total Accounts Payable | -82.14% | -42.88% | |||
| Total Accrued Expenses | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | -93.72% | -82.20% | |||
|
|
|||||
| Total Current Liabilities | -93.72% | -82.20% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | 0.00% | |||
| Total Liabilities | -94.56% | -76.75% | |||
|
|
|||||
| Common Stock & APIC | 6.41% | 14.49% | |||
| Retained Earnings | 38.12% | 27.21% | |||
| Treasury Stock & Other | -95.57% | -95.57% | |||
| Total Common Equity | 101.48% | 77.98% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 101.48% | 77.98% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 101.48% | 77.98% | |||
|
|
|||||